|
JPS5149971Y2
(en)
*
|
1971-02-17 |
1976-12-02 |
|
|
|
CH543763A
(en)
*
|
1971-05-05 |
1973-04-13 |
Ebauches Sa |
Calendar timepiece
|
|
CH1454271A4
(en)
*
|
1971-10-06 |
1976-07-30 |
|
|
|
CH1576671A4
(en)
*
|
1971-10-29 |
1975-10-31 |
|
|
|
US3969888A
(en)
*
|
1972-12-11 |
1976-07-20 |
Cyril Veuilleumier |
Driving mechanism for day-date calendar device
|
|
DE2824917A1
(en)
|
1977-07-13 |
1979-02-01 |
Corning Glass Works |
BIOLOGICALLY ACTIVE CONJUGATES
|
|
EP0042755B1
(en)
*
|
1980-06-20 |
1988-08-24 |
Unilever Plc |
Processes and apparatus for carrying out specific binding assays
|
|
US4443112A
(en)
*
|
1982-09-29 |
1984-04-17 |
Timex Corporation |
Planetary gear for date mechanism in a wristwatch
|
|
JPS62231168A
(en)
|
1986-03-21 |
1987-10-09 |
ハイブリテツク・インコ−ポレイテツド |
Improvement method for forming internal standard for analyzing analite-receptor
|
|
US6562333B1
(en)
|
1993-06-14 |
2003-05-13 |
Schering Corporation |
Purified mammalian CTLA-8 antigens and related reagents
|
|
US5869451A
(en)
|
1995-06-07 |
1999-02-09 |
Glaxo Group Limited |
Peptides and compounds that bind to a receptor
|
|
CN1315870C
(en)
|
1995-06-07 |
2007-05-16 |
葛兰素集团有限公司 |
Peptides and compounds that bind thrombopoietin receptor
|
|
AU4055697A
(en)
|
1996-08-16 |
1998-03-06 |
Schering Corporation |
Mammalian cell surface antigens; related reagents
|
|
ATE399861T1
(en)
|
1996-12-13 |
2008-07-15 |
Schering Corp |
SURFACE ANTIGENS FROM MAMMALS
|
|
ES2331622T3
(en)
|
1997-05-07 |
2010-01-11 |
Schering Corporation |
HUMAN RECEPTOR PROTEINS SIMILAR TO TOLL, REAGENTS AND RELATED METHODS.
|
|
EP0998496B1
(en)
|
1997-07-09 |
2008-05-28 |
Schering Corporation |
Isolated dendritic cell membrane protein genes
|
|
PE20000183A1
(en)
|
1997-07-25 |
2000-03-11 |
Schering Corp |
MAMMAL CYTOKINES AND RELATED REAGENTS
|
|
ATE523593T1
(en)
|
1997-08-01 |
2011-09-15 |
Schering Corp |
MAMMAL CELL MEMBRANE PROTEINS AND RELATED REAGENTS
|
|
EP1096952B1
(en)
|
1998-07-15 |
2008-05-21 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
|
WO2000017362A1
(en)
|
1998-09-21 |
2000-03-30 |
Schering Corporation |
Human interleukin-b50, therapeutic uses
|
|
EP0997476A3
(en)
|
1998-09-25 |
2000-07-19 |
Schering-Plough |
Antibodies to a mammalian Langerhans cell antigen and their uses
|
|
EP1141297B1
(en)
|
1999-01-11 |
2009-09-30 |
Schering Corporation |
Interleukin-17 related mammalian cytokines. polynucleotides encoding them . uses
|
|
MXPA01011519A
(en)
|
1999-05-13 |
2003-08-20 |
Medical Res Council |
Ox2 receptor homologs.
|
|
MXPA01012331A
(en)
|
1999-06-01 |
2002-07-30 |
Schering Corp |
Mammalian receptor proteins; related reagents and methods.
|
|
CA2376717A1
(en)
*
|
1999-06-16 |
2000-12-21 |
Icos Corporation |
Human poly(adp-ribose) polymerase 2 materials and methods
|
|
CA2379963C
(en)
|
1999-07-30 |
2014-03-25 |
Schering Corporation |
Mammalian cytokines; related reagents
|
|
US7668658B2
(en)
*
|
1999-10-13 |
2010-02-23 |
Sequenom, Inc. |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
|
US7109299B1
(en)
|
1999-12-16 |
2006-09-19 |
Affymax, Inc. |
Peptides and compounds that bind to the IL-5 receptor
|
|
PL209128B1
(en)
|
2000-05-10 |
2011-07-29 |
Schering Corp |
Mammalian cytokine receptor subunit proteins, related reagents and methods
|
|
US7422743B2
(en)
|
2000-05-10 |
2008-09-09 |
Schering Corporation |
Mammalian receptor protein DCRS5;methods of treatment
|
|
NZ522327A
(en)
|
2000-05-25 |
2004-09-24 |
Schering Corp |
Mammalian DNAX Toll-like receptor protein, DTLR 10, antibodies and medicaments made therefrom and use in treating immunological disorders
|
|
MXPA03002049A
(en)
|
2000-09-08 |
2003-07-24 |
Schering Corp |
Mammalian genes; related reagents and methods.
|
|
US6890734B2
(en)
|
2000-11-10 |
2005-05-10 |
Schering Corporation |
Nucleic acids encoding a cytokine receptor complex
|
|
US7087726B2
(en)
|
2001-02-22 |
2006-08-08 |
Genentech, Inc. |
Anti-interferon-α antibodies
|
|
WO2002072786A2
(en)
|
2001-03-13 |
2002-09-19 |
Corvas International, Inc. |
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
|
|
WO2002077263A2
(en)
|
2001-03-22 |
2002-10-03 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
|
|
US7105333B2
(en)
|
2001-03-27 |
2006-09-12 |
Deadreon Corporation |
Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
|
|
WO2002092841A2
(en)
|
2001-05-14 |
2002-11-21 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
|
|
EP1439188A4
(en)
|
2001-09-25 |
2006-04-26 |
Japan Government |
NEW SCREENING METHOD IN SEARCHING A CANCER MARKER
|
|
DE60231316D1
(en)
|
2001-10-12 |
2009-04-09 |
Schering Corp |
USE OF BIS-SPECIFIC ANTIBODIES AGAINST AN ACTIVATING RECEPTOR FcEpsilonRI AND AGAINST AN INHIBITING RECEPTOR OX2Ra (CD200Ra) FOR REGULATING IMMUNE RESPONSES
|
|
AU2002357004A1
(en)
*
|
2001-11-20 |
2003-06-10 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon
|
|
WO2003093296A2
(en)
*
|
2002-05-03 |
2003-11-13 |
Sequenom, Inc. |
Kinase anchor protein muteins, peptides thereof, and related methods
|
|
US20040001801A1
(en)
*
|
2002-05-23 |
2004-01-01 |
Corvas International, Inc. |
Conjugates activated by cell surface proteases and therapeutic uses thereof
|
|
US7575893B2
(en)
*
|
2003-01-23 |
2009-08-18 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
|
WO2005067692A2
(en)
*
|
2004-01-13 |
2005-07-28 |
U.S. Genomics, Inc. |
Detection and quantification of analytes in solution using polymers
|
|
AU2005241431A1
(en)
*
|
2004-04-16 |
2005-11-17 |
Genentech, Inc. |
Assay for antibodies
|
|
WO2005105830A1
(en)
|
2004-05-05 |
2005-11-10 |
Valorisation-Recherche, Societe En Commandite |
Interleukin-1 receptor antagonists, compositions, and methods of treatment
|
|
US20060014680A1
(en)
*
|
2004-07-13 |
2006-01-19 |
Caiding Xu |
Peptides and compounds that bind to the IL-5 receptor
|
|
KR20070085227A
(en)
*
|
2004-08-09 |
2007-08-27 |
앨리오스 바이오파마 인크. |
Synthetic hyperglycosylation, protease resistant polypeptide variants, oral preparations and methods using the same
|
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
EP2366786A3
(en)
|
2005-05-05 |
2012-08-29 |
VALORISATION HSJ, Société en Commandite |
Cytokine receptor modulators and uses thereof
|
|
US20100015654A1
(en)
*
|
2005-05-16 |
2010-01-21 |
Institut De Recherches Cliniques De Montreal/ I.R.C.M. |
Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells
|
|
US20100035247A1
(en)
*
|
2005-11-04 |
2010-02-11 |
U.S. Genomics, Inc. |
Heterogeneous Assay of Analytes in Solution Using Polymers
|
|
EP3156418A1
(en)
|
2006-01-05 |
2017-04-19 |
Genentech, Inc. |
Anti-ephb4 antibodies and methods using same
|
|
WO2007089641A2
(en)
|
2006-01-26 |
2007-08-09 |
The University Of Texas |
Process and apparatus for imaging
|
|
AR059851A1
(en)
|
2006-03-16 |
2008-04-30 |
Genentech Inc |
ANTIBODIES OF EGFL7 AND METHODS OF USE
|
|
US20080031816A1
(en)
*
|
2006-08-03 |
2008-02-07 |
Charles Keller |
Methods and compositions for identifying biomarkers
|
|
AR063125A1
(en)
|
2006-10-04 |
2008-12-30 |
Genentech Inc |
ELISA TEST FOR VEGF DETECTION
|
|
WO2008079322A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Beckman Coulter, Inc. |
Methods, kits and materials for diagnosing disease states by measuring isoforms or proforms of myeloperoxidase
|
|
PE20090321A1
(en)
|
2007-06-04 |
2009-04-20 |
Genentech Inc |
ANTI-NOTCH1 NRR ANTIBODIES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITION
|
|
EP2197911A2
(en)
|
2007-09-14 |
2010-06-23 |
Amgen Inc. |
Homogeneous antibody populations
|
|
AR069501A1
(en)
|
2007-11-30 |
2010-01-27 |
Genentech Inc |
ANTI-VEGF ANTIBODIES (VASCULAR ENDOTELIAL GROWTH FACTOR)
|
|
EP2324044A4
(en)
|
2008-08-04 |
2012-04-25 |
Univ Miami |
STING (INTERFERON GENE STIMULATOR), A REGULATOR OF INDIAN IMMUNE RESPONSES
|
|
MY182750A
(en)
*
|
2009-10-26 |
2021-02-05 |
Genentech Inc |
Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
|
|
WO2011057120A1
(en)
|
2009-11-05 |
2011-05-12 |
Genentech, Inc. |
Methods and composition for secretion of heterologous polypeptides
|
|
AR078377A1
(en)
|
2009-12-11 |
2011-11-02 |
Genentech Inc |
ANTI-VEGF-C ANTIBODIES (ISOLATED ANTI-VASCULAR ENDOTELIAL GROWTH FACTOR C) AND ITS METHODS OF USE
|
|
EP2516465B1
(en)
|
2009-12-23 |
2016-05-18 |
F.Hoffmann-La Roche Ag |
Anti-bv8 antibodies and uses thereof
|
|
WO2011091435A2
(en)
|
2010-01-25 |
2011-07-28 |
Mount Sinai School Of Medicine |
Methods of treating liver disease
|
|
WO2012030738A2
(en)
|
2010-08-30 |
2012-03-08 |
Beckman Coulter, Inc. |
Complex phosphoprotein activation profiles
|
|
WO2012092539A2
(en)
|
2010-12-31 |
2012-07-05 |
Takeda Pharmaceutical Company Limited |
Antibodies to dll4 and uses thereof
|
|
EP2702076A1
(en)
|
2011-04-29 |
2014-03-05 |
Bristol-Myers Squibb Company |
Ip-10 antibody dosage escalation regimens
|
|
KR102052983B1
(en)
|
2012-01-26 |
2019-12-06 |
크리스토퍼 제이. 소레스 |
Peptide antagonists of the calcitonin cgrp family of peptide hormones and their use
|
|
US9708411B2
(en)
|
2012-02-16 |
2017-07-18 |
The Penn Research Foundation |
Modulators of acyl-CoA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof
|
|
US20150079100A1
(en)
|
2012-03-23 |
2015-03-19 |
Bristol-Myers Squibb Company |
Methods of treatments using ctla-4 antibodies
|
|
EP2831119A1
(en)
*
|
2012-03-28 |
2015-02-04 |
F. Hoffmann-La Roche AG |
Anti-hcmv idiotypic antibodies and uses thereof
|
|
RU2014152261A
(en)
|
2012-05-30 |
2016-07-20 |
Дзе Брихэм Энд Уимен'З Хоспитал, Инк. |
COMPOSITIONS OF POLYSACCHARIDES AND METHODS OF APPLICATION
|
|
SG11201500938XA
(en)
|
2012-08-31 |
2015-04-29 |
Immunogen Inc |
Diagnostic assays and kits for detection of folate receptor 1
|
|
CA2884309A1
(en)
|
2012-09-07 |
2014-03-13 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for regenerating hair cells and/or supporting cells from differentiated cochlear cells or differentiated utricular cells by modulation of notch and cmyc activity
|
|
US9733263B2
(en)
|
2012-11-07 |
2017-08-15 |
Lotus Tissue Repair Inc. |
Collagen IV binding assay for the detection of collagen VII
|
|
MX371496B
(en)
|
2013-08-30 |
2020-01-31 |
Immunogen Inc |
ANTIBODIES AND ASSAYS FOR THE DETECTION OF FOLATE RECEPTOR 1.
|
|
EP4331605A3
(en)
|
2013-09-13 |
2024-05-22 |
F. Hoffmann-La Roche AG |
Methods and compositions comprising purified recombinant polypeptides
|
|
JP6546178B2
(en)
|
2013-09-13 |
2019-07-17 |
ジェネンテック, インコーポレイテッド |
Compositions and methods for detecting and quantifying host cell proteins and recombinant polypeptide products in cell lines
|
|
EP3058086B1
(en)
|
2013-10-18 |
2018-04-25 |
University Health Network |
Proteasome inhibition assay and methods of use
|
|
AU2015229035B2
(en)
|
2014-03-14 |
2021-08-05 |
Genentech, Inc. |
Methods and compositions for secretion of heterologous polypeptides
|
|
WO2016069906A1
(en)
|
2014-10-29 |
2016-05-06 |
Massachusetts Eye And Ear Infirmary |
Efficient delivery of therapeutic molecules to cells of the inner ear
|
|
WO2016069910A1
(en)
|
2014-10-29 |
2016-05-06 |
Massachusetts Eye And Ear Infirmary |
Methods for efficient delivery of therapeutic molecules in vitro and in vivo
|
|
SG11201707186YA
(en)
|
2015-03-06 |
2017-10-30 |
Genentech Inc |
Ultrapurified dsba and dsbc and methods of making and using the same
|
|
JP6492928B2
(en)
*
|
2015-04-22 |
2019-04-03 |
セイコーエプソン株式会社 |
Timepiece and timepiece manufacturing method
|
|
EP3341415B1
(en)
|
2015-08-28 |
2021-03-24 |
H. Hoffnabb-La Roche Ag |
Anti-hypusine antibodies and uses thereof
|
|
EP3391048B1
(en)
|
2015-12-15 |
2021-07-07 |
Case Western Reserve University |
Oral squamous cell carcinoma evaluation using beta defensin
|
|
MX2018012550A
(en)
|
2016-04-14 |
2019-07-08 |
Lonza Ag |
Compositions and methods for the detection of host cell proteins.
|
|
EP3316048B1
(en)
*
|
2016-10-28 |
2020-03-18 |
Rolex Sa |
Clockwork mechanism for displaying and correcting a plurality of information
|
|
WO2018136553A1
(en)
|
2017-01-18 |
2018-07-26 |
Genentech, Inc. |
Idiotypic antibodies against anti-pd-l1 antibodies and uses thereof
|
|
CH713604A1
(en)
|
2017-03-22 |
2018-09-28 |
Sa De La Manufacture Dhorlogerie Audemars Piguet & Cie |
Selection and actuation mechanism as well as a device for adjusting the functions of a timepiece.
|
|
JP6740323B2
(en)
*
|
2017-07-25 |
2020-08-12 |
ブランパン・エス アー |
Torque smoothing for timers, especially timers with a strike mechanism
|
|
EP3584643B1
(en)
*
|
2018-06-19 |
2020-11-11 |
Manufacture d'Horlogerie Audemars Piguet SA |
Instantaneous command device for date display of timepieces
|
|
EP3786725A1
(en)
*
|
2019-08-26 |
2021-03-03 |
Blancpain SA |
Disengagement of two gear trains
|
|
CN115461375A
(en)
|
2020-04-30 |
2022-12-09 |
基因泰克公司 |
KRAS-specific antibodies and uses thereof
|
|
WO2022081436A1
(en)
|
2020-10-15 |
2022-04-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibody specific for sars-cov-2 receptor binding domain and therapeutic methods
|
|
WO2022087274A1
(en)
|
2020-10-21 |
2022-04-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibodies that neutralize type-i interferon (ifn) activity
|
|
WO2022178255A2
(en)
|
2021-02-19 |
2022-08-25 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies that neutralize sars-cov-2
|
|
CH718513A1
(en)
*
|
2021-04-07 |
2022-10-14 |
Mft Dhorlogerie Audemars Piguet Sa |
Device for selecting and actuating several functions of a watch movement.
|